Literature DB >> 11992566

Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse.

Andrew C H Chen1, K Steven LaForge, Ann Ho, Pauline F McHugh, Scott Kellogg, Kathy Bell, Rosemary P Schluger, Suzanne M Leal, Mary Jeanne Kreek.   

Abstract

It has been demonstrated that the opioid peptide dynorphin plays a role in modulating responses to several psychoactive substances including cocaine. Our laboratory and others have found that mRNA levels of dynorphin in the caudate and putamen are elevated after acute or chronic cocaine exposure in rats. Recently, a 68-base pair (bp) repeat polymorphism within the core promoter region of the human prodynorphin gene has been reported to occur in alleles containing one, two, three, or four copies. This repeat contains a putative AP-1 transcription factor binding site; reporter gene constructs with three or four, but not one or two, copies of the tandem repeats were shown to be associated with increases in transcriptional activation in in vitro cellular assays. We hypothesize that this polymorphism may be associated with individual differences in vulnerability to cocaine dependence or abuse. From an ongoing study of the genetics of addiction, 174 subjects were studied, including individuals with a primary diagnosis (DSM-IV criteria) of cocaine dependence (N = 61) or abuse (N = 22), and controls with no history of any substance dependence or abuse (N = 91). We designed primers for polymerase chain reaction (PCR) to amplify sequences of the promoter region of the prodynorphin gene containing the repeat element. The association of alleles containing three or four repeats with cocaine dependence/abuse was examined. With data stratified by ethnic group, pooled relative risk (RR) with Mantel-Haenszel Chi square was calculated: RR = 0.59 (95% confidence interval 0.37-0.95), chi2 (1) = 4.14, P = 0.042. Our results suggest that this allelic variation at the promoter region of the prodynorphin gene (alleles with three or four repeats), which may result in enhanced transcription of the gene, may contribute to relative protection and decrease individual vulnerability to develop cocaine dependence or abuse. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992566      PMCID: PMC6148755          DOI: 10.1002/ajmg.10362

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  36 in total

1.  Association mapping in structured populations.

Authors:  J K Pritchard; M Stephens; N A Rosenberg; P Donnelly
Journal:  Am J Hum Genet       Date:  2000-05-26       Impact factor: 11.025

2.  Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor.

Authors:  S Nakanishi; A Inoue; T Kita; M Nakamura; A C Chang; S N Cohen; S Numa
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

3.  Dopamine antagonist and "binge' cocaine effects on rat opioid and dopamine transporter mRNAs.

Authors:  R Spangler; Y Zhou; C E Maggos; A Zlobin; A Ho; M J Kreek
Journal:  Neuroreport       Date:  1996-09-02       Impact factor: 1.837

Review 4.  Drugs of abuse: anatomy, pharmacology and function of reward pathways.

Authors:  G F Koob
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

Review 5.  Genetic dissection of complex traits.

Authors:  E S Lander; N J Schork
Journal:  Science       Date:  1994-09-30       Impact factor: 47.728

6.  Isolation and structural organization of the human preproenkephalin gene.

Authors:  M Noda; Y Teranishi; H Takahashi; M Toyosato; M Notake; S Nakanishi; S Numa
Journal:  Nature       Date:  1982-06-03       Impact factor: 49.962

7.  Comparison of acute effects of dynorphin and beta-endorphin on prolactin release in the rat.

Authors:  D A Van Vugt; P W Sylvester; C F Aylsworth; J Meites
Journal:  Endocrinology       Date:  1981-05       Impact factor: 4.736

8.  Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum.

Authors:  J B Daunais; D C Roberts; J F McGinty
Journal:  Neuroreport       Date:  1993-05       Impact factor: 1.837

Review 9.  Why different rules are required for polygenic inheritance: lessons from studies of the DRD2 gene.

Authors:  D E Comings
Journal:  Alcohol       Date:  1998-07       Impact factor: 2.405

10.  Forskolin induces preproenkephalin and preprodynorphin mRNA in rat striatum as demonstrated by in situ hybridization histochemistry.

Authors:  J N Simpson; J F McGinty
Journal:  Synapse       Date:  1995-03       Impact factor: 2.562

View more
  26 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 2.  An overview of the genetics of substance use disorders.

Authors:  H M Lachman
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

3.  Poststress block of kappa opioid receptors rescues long-term potentiation of inhibitory synapses and prevents reinstatement of cocaine seeking.

Authors:  Abigail M Polter; Rachel A Bishop; Lisa A Briand; Nicholas M Graziane; R Christopher Pierce; Julie A Kauer
Journal:  Biol Psychiatry       Date:  2014-05-21       Impact factor: 13.382

Review 4.  Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.

Authors:  Vadim Yuferov; Orna Levran; Dmitri Proudnikov; David A Nielsen; Mary Jeanne Kreek
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

5.  Alcohol dependence, disinhibited behavior and variation in the prodynorphin gene.

Authors:  Janine D Flory; Carolyn L Pytte; Yasmin Hurd; Robert E Ferrell; Stephen B Manuck
Journal:  Biol Psychol       Date:  2011-07-05       Impact factor: 3.251

6.  A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats.

Authors:  Jennifer M Mitchell; Marisa T Liang; Howard L Fields
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

7.  A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain.

Authors:  Vadim Yuferov; Fei Ji; David A Nielsen; Orna Levran; Ann Ho; Susan Morgello; Ruijin Shi; Jurg Ott; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

8.  Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity.

Authors:  Nicholas M Graziane; Abigail M Polter; Lisa A Briand; R Christopher Pierce; Julie A Kauer
Journal:  Neuron       Date:  2013-03-06       Impact factor: 17.173

Review 9.  Genes associated with addiction: alcoholism, opiate, and cocaine addiction.

Authors:  Mary Jeanne Kreek; David A Nielsen; K Steven LaForge
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 10.  Implications of genome wide association studies for addiction: are our a priori assumptions all wrong?

Authors:  F Scott Hall; Jana Drgonova; Siddharth Jain; George R Uhl
Journal:  Pharmacol Ther       Date:  2013-07-18       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.